Study to Evaluate the Safety and Efficacy of 13 Weeks of the Selective Androgen Receptor Modulator (SARM) GSK2881078 in Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT03359473 · COMPLETED
Trial details
- NCT number
- NCT03359473
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-28
- Primary completion
- 2019-11-19
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.